BAYpress November 2015

WuXi News

Gilead Sciences and WuXi Partner for a Dedicated Analytical and Stability Testing Facility

WuXi and Lilly Collaborate to Develop Novel Therapeutics in China

WuXi Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

Congratulations to Novira Therapeutics for its Acquisition Agreement with Johnson & Johnson

Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project 

Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar

WuXi Launches Mobile OncoWuXi, the World’s First App for Accessing Oncology Services

 Read full article here

Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi Headquarters in Shanghai
Perspectives

Prospects for Cell and Gene Therapy: An Interview with Alan Moore, Vice President of Strategic Accounts and Cell Manufacturing 
In This Issue
Industry Beats

Breakout Labs Introduces New Portfolio Companies: nanoGriptech, Maxterial, C2Sense and CyteGen (Source: Breakout Labs)

Google Life Science and The American Heart Association Announce Collaboration to Change Trajectory of Heart Disease (Source: American Heart Association)

AstraZeneca Strengthens Cardiovascular and Metabolic Disease Portfolio with Acquisition of ZS Pharma (Source: AstraZeneca)

Portola Rolls Toward Approval for its Breakthrough Anticoagulant Antidote (Source: FierceBiotech)

Desktop Genetics Partners with Transcriptic (Source: Transcriptic)

Ginkgo Bioworks To Purchase 100 Million Base Pairs of Synthetic DNA from Twist Bioscience to Meet Growing Customer Demand for Biological Manufacturing (Source: Twist Bioscience)

Andreessen Horowitz Launches $200 Million Biotech Software Led By New Partner Vijay Pande (Source: Forbes)

Atreca Gets $56M from Gates Foundation and GSK to Advance Novel Cancer
Immunotherapies (Source: Atreca)

KaloBios Appoints Martin Shkreli CEO and Announces New Financing  (Source: KalosBio)

Threshold Pharmaceuticals Enters into Co-promotion Agreement for Evofosfamide with Merck (Source: Threshold)

FDA Approvals & Designations

Upcoming Events

December 2-3, 2015
San Jose Convention Center
 
December 2-3, 2015
Napa, CA
 
December 10, 2015
Amgen, South San Francisco
 
January 11, 2015
San Francisco, CA
 
January 11, 2015
JP Morgan Healthcare Conference 2016
San Francisco, CA

 

Forward this email

This email was sent to by communications@wuxiapptec.com |

 

WuXi AppTec | 953 Indiana St | San Francisco | CA | 94158

 

 

ILpress November 2015

UPCOMING: WuXi Representatives Visit Israel for EFMC-ASMC’15

 

 

Members of WuXi’s small molecule drug discovery platform (International Discovery Service Unit – IDSU) will be attending the EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry from November 15-18 to meet with Israeli clients and colleagues. WuXi brings world class capability and capacity through its open access platform so that anyone and any company can discover and develop healthcare products to benefit patients.
“Our team looks forward to fostering the small molecule innovation of Israeli entrepreneurs and to helping advance the world class science found in Israel” says Richard Soll, Senior VP, IDSU.
“I look forward to catching up with current and prospective clients face-to-face, and continuing to find ways to support and build our partnerships in this exciting discovery hub” says David Madge, IDSU’s Program Director.
Please contact Dana Yarden, Executive Director of Business Development, Israel for further details on WuXi’s services and IDSU’s trip to Israel.

 

 

Perspectives

Prospects for U.S. and Israel Cell and Gene Therapy: An Interview with Alan Moore, Vice President of Strategic Accounts and Cell Manufacturing 
WuXi News

WuXi and Lilly Collaborate to Develop Novel Therapeutics in China

Congratulations to Novira Therapeutics for its Acquisition Agreement with Johnson & Johnson

Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project 

Gilead Sciences and WuXi Partner for a Dedicated Analytical and Stability Testing Facility

WuXi Launches Medical Device Testing Services in China

Read full article here

WuXi Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar

WuXi Launches Mobile OncoWuXi, the World’s First App for Accessing Oncology Services

 Read full article here

Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi Headquarters in Shanghai
In This Issue
Industry Beats

FDA Approvals & Designations

Upcoming Events

November 23, 2015
TechnoSTAT

 

December 2, 2015
IBM Israel, Tel Aviv
 
December 8, 2015
Hilton Hotel, Tel Aviv
 
December 13- 15, 2015
Intercontinental David, Tel Aviv
 
December 14-17, 2015
Tel Aviv University

 

MApress October 2015

WuXi News

WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

WuXi Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

WuXi Boston Welcomes Valdas Jurkauskas to Join the STA Team: An Interview with Valdas Jurkauskas, Executive Director, Technical Operations, WuXi STA

WuXi Hosts Symposium in Cambridge: Expediting Your Preclinical Development Timeline with an Integrated CRO

WuXi NextCODE in Bloomberg on Ending a 30-year Diagnostic Odyssey in 3 Weeks

Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar

Read full article here

WuXi NextCODE and Fudan Children’s Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China 

WuXi Launches Mobile OncoWuXi, the World’s First App for Accessing Oncology Services

Read full article here

Thirteen New Suppliers Have Joined LabNetwork’s October 2nd Release  

 

Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi Headquarters in Shanghai  
Perspectives

Meet WuXi’s Israeli Partner: An Interview with Ran Nussbaum, Co-Founder and Managing Partner of Pontifax
In This Issue
Industry Beats

FDA Approvals & Designations

Upcoming Events

October 26-29, 2015
Hynes Convention Center, Boston, MA
October 29, 2015
Merck Boston Auditorium, Boston, MA


October 27, 2015
Google’s Cambridge Headquarters, 355 Main Street, Cambridge, MA
November 5, 2015
Online
 
November 9-10, 2015
Seaport World Trade Center, Boston, MA
November 13, 2015
Renaissance Boston Waterfront Hotel, Boston, MA
November 17-18, 2015
Harvard Club, Cambridge, MA

BAYpress September 2015

WuXi News

WuXi NextCODE in Bloomberg on Ending a 30-year Diagnostic Odyssey in 3 Weeks

WuXi NextCODE Featured in Nature as the Innovative Engine of Population-scale Precision Medicine at Genomics England and Beyond 

WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

WuXi NextCODE and Fudan Children’s Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China 

WuXi’s STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm

WuXi and TruTag Technology Advances Edible On-Dose Authentication Solution for Pharmaceuticals 
Perspectives

An Interview with Dr. Steve Yang, EVP and COO of WuXi AppTec and the New Head of IDSU

Meet WuXi’s Israel Partner: An Interview with Ran Nussbaum, Co-Founder and Managing Partner of Pontifax
In This Issue:
Industry Beats

 

 

 

 

 

 

Penumbra, Inc. Announces Pricing of Initial Public Offering (Source: Penumbra)

Versant Ventures Broadens Geographic Footprint with Highline Therapeutics (Source: Versant Ventures)

FDA Approvals & Designations

Upcoming Events

September 30, 2015
Online
 
October 13, 2015
CLSA, South San Francisco
 
October 27, 2015
California Academy of Sciences
 
October 27-28, 2015
Santa Clara Convention Center
November 3-4, 2015
Hyatt Regency San Francisco Airport
WuXi AppTec
953 Indiana Street
San Francisco, CA 94107

Follow us on TwitterView our profile on LinkedIn

 

SDpress October 2015

 

WuXi News

Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi Headquarters in Shanghai  

WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

WuXi Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

WuXi NextCODE in Bloomberg on Ending a 30-year Diagnostic Odyssey in 3 Weeks

Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar

Read full article here

WuXi NextCODE and Fudan Children’s Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China 

WuXi Launches Mobile OncoWuXi, the World’s First App for Accessing Oncology Services

Read full article here

WuXi Launches Medical Device Testing Services in China

Perspectives

An Interview with Valdas Jurkauskas, Executive Director, Technical Operations, WuXi STA

Meet WuXi’s Israeli Partner: An Interview with Ran Nussbaum, Co-Founder and Managing Partner of Pontifax
In This Issue
Industry Beats

FDA Approvals & Designations

Upcoming Events

November 5, 2015
Conrad T. Prebys Auditorium, Salk Institute 
 
November 8, 2015
Salk Institute
 
November 10, 2015
Auditorium at TSRI, The Scripps Research Institute
 
November 17, 2015
Biocom, San Diego
 
December 7-10, 2015
San Diego Convention Center

 

IL Press September 2015

Meet WuXi’s Israel Partner: An Interview with Ran Nussbaum, Co-Founder and Managing Partner of Pontifax  

Wuxi City Mayor Visits WuXi’s Israel Office

The Wuxi government delegation visited Israel last week exploring ways to promote economic transformation for Wuxi city through developing advanced technologies and cultivating potential collaborations between Israel and Wuxi companies. Dana Yarden of WuXi’s Israel Office had the opportunity to present to the delegation on general economic trends in Israel and on WuXi AppTec’s activities in Israel.

Innovation That Matters

WuXi NextCODE in Bloomberg on Ending a 30-year Diagnostic Odyssey in 3 Weeks
 

WuXi NextCODE Featured in Nature as the Innovative Engine of Population-scale Precision Medicine at Genomics England and Beyond

 
WuXi News

WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan
  
  

WuXi NextCODE and Fudan Children’s Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China

WuXi’s STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm

WuXi and TruTag Technology Advances Edible On-Dose Authentication Solution for Pharmaceuticals

Perspectives

Meet the New Head of IDSU: An Interview with Dr. Steve Yang

An Interview with Dr. Paul Liu, Vice President and Head of Biosafety Testing Services in Suzhou China

In This Issue
 
Industry Beats

 

FDA Approvals & Designations


 
Upcoming Events

September 30, 2013
Online

October 18, 2015
HP Software, Yehud
October 26, 2015
Hilton Hotel Tel Aviv
Follow us on TwitterView our profile on LinkedIn